Last reviewed · How we verify
NCT01541111
Evaluation of Analgesic Effect of Magnesiun Associated With Morphine for Cancer Pain Relief
NA trial testing Magnesiun in Cancer-related Problem/Condition in 40 participants. Completed in 1 March 2014.
1 March 2014
Quick facts
| Lead sponsor | Federal University of São Paulo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2011 |
| Primary completion | 1 March 2014 |
| Estimated completion | 1 March 2014 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Magnesiun — full drug profile →
Conditions studied
- Cancer-related Problem/Condition — all drugs for Cancer-related Problem/Condition →
Sponsor
Federal University of São Paulo
Who can join
Adults 18 to 75, any sex, with Cancer-related Problem/Condition. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Pain relief
Time frame: 12 wk
Sponsor's own description
This study is an evaluation of the analgesic effect of magnesium associated with morphine in patients with cancer pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01541111
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer-related Problem/Condition
Currently open trials in the same condition.
- NCT06754722 — Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors · NA · recruiting
- NCT06839794 — Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients · NA · recruiting
- NCT06809101 — Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Bal · recruiting
- NCT06717178 — Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China · recruiting
- NCT05891431 — Engagement and Acceptability of the Untire mHealth App · NA · active not recruiting
Other Federal University of São Paulo trials
Trials by the same sponsor.
- NCT07376811 — Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome · NA · not yet recruiting
- NCT06805656 — Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals · Phase 2 · not yet recruiting
- NCT06970964 — Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before a · NA · completed
- NCT06905860 — Intra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis · Phase 4 · not yet recruiting
- NCT06829992 — Effects of Applying Kinesio Tapping on Primary Dysmenorrhea in Football Players · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01541111 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of São Paulo
- Last refreshed: 27 July 2015
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01541111.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing